Search

everythinglearnresearchcommunity

for

Search:↓

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Ginsenoside Rb1 slows down aging in mice by affecting cell growth, cell death, and metabolism.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Certain drugs can cause early hair growth in mice by affecting the nerves.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

A gene network led by RSL4 is crucial for early root hair growth in response to cold in Arabidopsis thaliana.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Propranolol affects heart rate and renin levels in minoxidil-treated patients.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

The new microneedle system promotes hair growth by improving the hair follicle environment.

Setipiprant did not significantly improve hair growth in men with hair loss.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

The treatment successfully lowered testosterone levels and reduced symptoms.

Minoxidil lowers blood pressure more effectively but has more side effects, so try hydralazine first.

CRH promotes fat production in skin cells, affecting conditions like acne.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.